Uh-oh! This study is no longer available.
Nonalcoholic Steatohepatitis (NASH) and Liver Fibrosis
Non-Alcoholic Fatty Liver Disease
PMG Research of Winston Salem
18 and older
A research study is being conducted to evaluate the safety and efficacy of an investigational combination of medication for Nonalcoholic Steatohepatitis (NASH) and liver fibrosis.
This research study may be an option if you:
• Are suspected to have NASH with fibrosis (potential risk factors include obesity, high blood pressure, high cholesterol or Type 2 Diabetes)
• Are willing to undergo liver biopsies
• Have no other forms of chronic liver disease
Those with diabetes should have an HbA1c below 9%. Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you. Study participation is completely voluntary.
Qualified participants will receive all study-related care and study medication at no cost.
Patient Commitment Duration
Approximately 1 year
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 13 clinic visits